![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Rigshospitalet, Denmark |
---|---|
Information provided by: | Rigshospitalet, Denmark |
ClinicalTrials.gov Identifier: | NCT00531687 |
Study Objectives:
Primary objective
· The primary objective of this study is to investigate the combination of cisplatin/gemcitabine/paclitaxel, with respect to complete remission in patients with germ cell tumours previously treated with BEP.
Secondary Objectives
Condition | Intervention | Phase |
---|---|---|
Testicular Cancer Relapse |
Drug: cisplatin, gemcitabine, paclitaxel |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Single Group Assignment, Safety/Efficacy Study |
Study Start Date: | September 2007 |
Ages Eligible for Study: | 18 Years to 70 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Gedske Daugaard, MD, DMSc | 0045 35454677 | gedske.daugaard@rh.regionh.dk |
Denmark | |
Department of Oncology 5073, Rigshospitalet | Recruiting |
Copenhagen, Denmark, 2100 | |
Principal Investigator: Gedske Daugaard, MD, DMSc |
Principal Investigator: | Gedske Daugaard, MD, DMSc | Rigshospitalet, Denmark |
Study ID Numbers: | Relapse testis cancer 2007 |
Study First Received: | September 18, 2007 |
Last Updated: | September 18, 2007 |
ClinicalTrials.gov Identifier: | NCT00531687 |
Health Authority: | Denmark: Danish Dataprotection Agency; Denmark: Danish Medicines Agency; Denmark: Ethics Committee |
Genital Neoplasms, Male Gonadal Disorders Testicular Diseases Endocrine System Diseases Urogenital Neoplasms Testicular Neoplasms Genital Diseases, Male |
Malignant germ cell tumor Cisplatin Paclitaxel Testicular cancer Endocrinopathy Gemcitabine Endocrine Gland Neoplasms |
Antimetabolites Anti-Infective Agents Antimetabolites, Antineoplastic Immunologic Factors Molecular Mechanisms of Pharmacological Action Antineoplastic Agents Mitosis Modulators Physiological Effects of Drugs Enzyme Inhibitors Antimitotic Agents |
Immunosuppressive Agents Antiviral Agents Pharmacologic Actions Neoplasms Neoplasms by Site Radiation-Sensitizing Agents Therapeutic Uses Tubulin Modulators Antineoplastic Agents, Phytogenic |